Keratinocyte-Associated B7-H1 Directly Regulates Cutaneous Effector CD8+ T Cell Responses

Keratinocytes (KCs) may play important roles for maintenance of peripheral tolerance in the upper layers of the skin. Coinhibitory signals mediated via the programmed death (PD)-1 and its ligand B7-H1 (PD-L1/CD274) are crucial for the downregulation of T cell immune responses and for the maintenance of peripheral tolerance. In this study, to investigate the role of KC-expressed B7-H1 in the regulation of T cell immune responses, we generated transgenic (tg) mice overexpressing B7-H1 under the control of keratin 14 (K14) promoter (K14-B7-H1 tg). K14-B7-H1 tg mice displayed impaired contact hypersensitivity (CH) responses to primary and secondary hapten challenges. The K14-B7-H1 tg mice did not exhibit substantial impairment of cutaneous dendritic cell migration after sensitization and of hapten-specific proliferation and IFN-γ production of CD4+ and CD8+ T cells in the draining lymph nodes, suggesting that overexpression of B7-H1 on KCs did not affect the induction phase of the CH response. The systemic or s.c. injection of hapten-sensitized T cells into the K14-B7-H1 tg mice did not efficiently induce the CH response. IFN-γ expression and apoptosis of KCs in the challenged ears were impaired in K14-B7-H1 tg mice. IFN-γ production by presensitized CD8+ T cells stimulated with hapten-pulsed KCs was markedly impaired for the KCs obtained from the K14-B7-H1 tg mice but was restored by the addition of an anti–B7-H1 mAb. These results suggest that KC-associated B7-H1 directly downregulates the effector function of CD8+ T cells by associating with PD-1 at local inflammatory sites and that it plays a role in peripheral T cell tolerance against exogenous Ags.

[1]  Frank O. Nestle,et al.  Skin immune sentinels in health and disease , 2009, Nature Reviews Immunology.

[2]  M. Azuma,et al.  Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes , 2009, Immunology.

[3]  S. Gambhir,et al.  Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. , 2009, Blood.

[4]  R. Fairchild,et al.  CD8 T Cells Producing IL-17 and IFN-γ Initiate the Innate Immune Response Required for Responses to Antigen Skin Challenge1 , 2009, The Journal of Immunology.

[5]  M. Azuma,et al.  The Glucocorticoid-Induced TNF Receptor-Related Protein (GITR)-GITR Ligand Pathway Acts As a Mediator of Cutaneous Dendritic Cell Migration and Promotes T Cell-Mediated Acquired Immunity1 , 2009, The Journal of Immunology.

[6]  J. Dutz T-cell-mediated injury to keratinocytes: insights from animal models of the lichenoid tissue reaction. , 2009, The Journal of investigative dermatology.

[7]  G. Freeman,et al.  Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. , 2008, Blood.

[8]  D. Chang,et al.  Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice , 2008, Diabetes.

[9]  M. Azuma,et al.  Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  G. Freeman,et al.  PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.

[11]  Lieping Chen,et al.  Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7‐homolog 1‐dependent CD8+ T cell tolerance , 2007, Hepatology.

[12]  G. Freeman,et al.  The Function of Donor versus Recipient Programmed Death-Ligand 1 in Corneal Allograft Survival1 , 2007, The Journal of Immunology.

[13]  L. Jones,et al.  Human keratinocyte induction of rapid effector function in antigen‐specific memory CD4+ and CD8+ T cells , 2007, European journal of immunology.

[14]  A. Iwasaki Mucosal dendritic cells. , 2007, Annual review of immunology.

[15]  F. Vincenti,et al.  T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. , 2007, Annual review of medicine.

[16]  Yi-hong Wang,et al.  Cutting Edge: Programed Death (PD) Ligand-1/PD-1 Interaction Is Required for CD8+ T Cell Tolerance to Tissue Antigens1 , 2006, The Journal of Immunology.

[17]  J. Bluestone,et al.  Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway , 2006, The Journal of experimental medicine.

[18]  K. Okumura,et al.  B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts1 , 2006, The Journal of Immunology.

[19]  G. Freeman,et al.  Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade , 2006, The Journal of experimental medicine.

[20]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[21]  L. Lefrançois,et al.  Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. , 2006, Annual review of immunology.

[22]  R. Ahmed,et al.  Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.

[23]  M. Isobe,et al.  Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[24]  K. Omura,et al.  The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. , 2004, Immunology letters.

[25]  G. Zhu,et al.  B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. , 2004, Immunity.

[26]  Lieping Chen,et al.  Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. , 2004, The Journal of clinical investigation.

[27]  G. Freeman,et al.  Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis , 2003, European journal of immunology.

[28]  S. Khoury,et al.  The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice , 2003, The Journal of experimental medicine.

[29]  T. Curiel,et al.  Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity , 2003, Nature Medicine.

[30]  D. Pardoll,et al.  Expression of Programmed Death 1 Ligands by Murine T Cells and APC1 , 2002, The Journal of Immunology.

[31]  Yoshimasa Tanaka,et al.  Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Kehren,et al.  Skin Inflammation During Contact Hypersensitivity Is Mediated by Early Recruitment of CD8+ T Cytotoxic 1 Cells Inducing Keratinocyte Apoptosis1 , 2002, The Journal of Immunology.

[33]  H. Hashimoto,et al.  Preferential Blockade of CD8+ T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases1 , 2001, The Journal of Immunology.

[34]  T. Luger,et al.  Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. , 1995, Journal of immunology.

[35]  L. Turka,et al.  Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. , 1994, Immunology today.

[36]  C. Thompson,et al.  Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. , 1994, Journal of immunology.

[37]  C. Thompson,et al.  Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. , 1993, Journal of immunology.

[38]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[39]  T. Honjo,et al.  Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.

[40]  A. Enk,et al.  Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Gaspari,et al.  Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes. , 1991, Journal of immunology.

[42]  R. Steinman,et al.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro , 1985, The Journal of experimental medicine.

[43]  References Subscriptions Permissions Email Alerts PDL1 Is Required for Peripheral Transplantation Tolerance and Protection from Chronic Allograft Rejection , 2013 .

[44]  Shih-Hua Lin,et al.  Protective Role of Programmed Death 1 Ligand 1 in Nonobese Diabetic Mice: The Paradox in Transgenic Models , 2008 .

[45]  G. Freeman,et al.  The B7 family revisited. , 2005, Annual review of immunology.

[46]  津島 文彦 Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses , 2003 .

[47]  G. Zhu,et al.  Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.

[48]  J. Bluestone,et al.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. , 2001, Annual review of immunology.